Vlad Coric

Vlad Coric is currently a Board Member at Vita Therapeutics. Prior to that, they were Principal - Equity Research Analyst at Brown Advisory from September 2015 to October 2019, focusing on Biotechnology and Healthcare. Before that, they were Investment Analyst at Merrill Lynch from January 2014 to December 2015. Vlad started their career as an M&A Research Analyst Intern at Lazard from September 2012 to December 2012.

Vlad Coric has a Master's degree in Biotechnology from The Johns Hopkins University and an Economics and Business Management degree with a concentration in Finance from Goucher College.